DA
CL icon

Dunvegan Associates’s Colgate-Palmolive CL Stock Holding History

Dunvegan Associates’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$51K Hold
762
– – 0.06% 93
2015
Q3 		$48K Hold
762
– – 0.05% 95
2015
Q2 		$50K Hold
762
– – 0.06% 93
2015
Q1 		$53K Hold
762
– – 0.05% 106
2014
Q4 		$53K Hold
762
– – 0.05% 105
2014
Q3 		$50K Hold
762
– – 0.05% 101
2014
Q2 		$52K Hold
762
– – 0.04% 102
2014
Q1 		$49K Buy
+762
New +$48K 0.04% 103

Other funds holding CL

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dunvegan Associates's CL Position: Q4 2015 in Review

Dunvegan Associates held its Colgate-Palmolive (CL) position steady in Q4 2015 at 762 shares worth $51K. The position accounts for 0.06% of the portfolio, ranked #93.

Dunvegan Associates first reported a position in CL in Q1 2014 and has held it in 8 quarters since. The position peaked at $53K in Q1 2015. 1,254 funds tracked by Wall St. Rank hold CL as of Q4 2015.

  • Dunvegan Associates held 762 shares of Colgate-Palmolive worth $51K as of Q4 2015.
  • Dunvegan Associates left its Colgate-Palmolive share count unchanged in Q4 2015.
  • Colgate-Palmolive made up 0.06% of Dunvegan Associates's portfolio in Q4 2015, its #93 holding.
  • Dunvegan Associates first reported a position in Colgate-Palmolive in Q1 2014 and has held it in 8 quarters since.
  • Dunvegan Associates's Colgate-Palmolive position peaked at $53K in Q1 2015.
  • 1,254 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.